6/3
08:03 am
nuvb
Nuvation Bio Inc. (NYSE: NUVB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
High
Report
Nuvation Bio Inc. (NYSE: NUVB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
6/1
08:21 am
nuvb
Nuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and Reported at 2024 ASCO Annual Meeting [Yahoo! Finance]
High
Report
Nuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and Reported at 2024 ASCO Annual Meeting [Yahoo! Finance]
6/1
08:10 am
nuvb
Nuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and Reported at 2024 ASCO Annual Meeting
High
Report
Nuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and Reported at 2024 ASCO Annual Meeting
5/29
04:24 pm
nuvb
Nuvation Bio to Present at the Jefferies Global Healthcare Conference [Yahoo! Finance]
Low
Report
Nuvation Bio to Present at the Jefferies Global Healthcare Conference [Yahoo! Finance]
5/29
04:05 pm
nuvb
Nuvation Bio to Present at the Jefferies Global Healthcare Conference
Low
Report
Nuvation Bio to Present at the Jefferies Global Healthcare Conference
5/24
10:08 am
nuvb
Nuvation Bio Inc. (NYSE: NUVB) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $5.00 price target on the stock.
Low
Report
Nuvation Bio Inc. (NYSE: NUVB) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $5.00 price target on the stock.
5/22
08:12 am
nuvb
Nuvation Bio Inc. (NYSE: NUVB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
Medium
Report
Nuvation Bio Inc. (NYSE: NUVB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
5/15
10:30 am
nuvb
Nuvation Bio Inc. (NYSE: NUVB) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $5.00 price target on the stock.
Medium
Report
Nuvation Bio Inc. (NYSE: NUVB) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $5.00 price target on the stock.
5/14
04:16 pm
nuvb
Nuvation Bio Reports First Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
Nuvation Bio Reports First Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
5/14
04:05 pm
nuvb
Nuvation Bio Reports First Quarter 2024 Financial Results and Provides Business Update
Neutral
Report
Nuvation Bio Reports First Quarter 2024 Financial Results and Provides Business Update
4/24
10:15 am
nuvb
Nuvation Bio to Present Updated Data on Taletrectinib, a ROS1 inhibitor, at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting [Yahoo! Finance]
Medium
Report
Nuvation Bio to Present Updated Data on Taletrectinib, a ROS1 inhibitor, at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting [Yahoo! Finance]
4/24
10:01 am
nuvb
Nuvation Bio to Present Updated Data on Taletrectinib, a ROS1 inhibitor, at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Low
Report
Nuvation Bio to Present Updated Data on Taletrectinib, a ROS1 inhibitor, at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
4/10
04:09 pm
nuvb
Nuvation Bio Completes Acquisition of AnHeart Therapeutics [Yahoo! Finance]
Medium
Report
Nuvation Bio Completes Acquisition of AnHeart Therapeutics [Yahoo! Finance]
4/10
04:01 pm
nuvb
Nuvation Bio Completes Acquisition of AnHeart Therapeutics
Medium
Report
Nuvation Bio Completes Acquisition of AnHeart Therapeutics
3/31
10:00 am
nuvb
Nuvation Bio: Strong Buy Off The Acquisition Of A Late-Stage Lung Cancer Candidate [Seeking Alpha]
Neutral
Report
Nuvation Bio: Strong Buy Off The Acquisition Of A Late-Stage Lung Cancer Candidate [Seeking Alpha]
3/31
04:55 am
nuvb
Week In Review: AriBio Sells China Rights To Alzheimer's Candidate In $770M Deal [Seeking Alpha]
Neutral
Report
Week In Review: AriBio Sells China Rights To Alzheimer's Candidate In $770M Deal [Seeking Alpha]
3/28
08:09 am
nuvb
Nuvation Bio Announces Appointment of Colleen Sjogren as Chief Commercial Officer [Yahoo! Finance]
Medium
Report
Nuvation Bio Announces Appointment of Colleen Sjogren as Chief Commercial Officer [Yahoo! Finance]
3/28
08:07 am
nuvb
Nuvation Bio Inc. (NYSE: NUVB) had its price target raised by analysts at HC Wainwright from $5.00 to $8.00. They now have a "buy" rating on the stock.
Medium
Report
Nuvation Bio Inc. (NYSE: NUVB) had its price target raised by analysts at HC Wainwright from $5.00 to $8.00. They now have a "buy" rating on the stock.
3/28
08:00 am
nuvb
Nuvation Bio Announces Appointment of Colleen Sjogren as Chief Commercial Officer
Medium
Report
Nuvation Bio Announces Appointment of Colleen Sjogren as Chief Commercial Officer
3/27
08:07 am
nuvb
Nuvation Bio Inc. (NYSE: NUVB) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $10.00 price target on the stock, up previously from $1.40.
High
Report
Nuvation Bio Inc. (NYSE: NUVB) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $10.00 price target on the stock, up previously from $1.40.
3/26
12:59 pm
nuvb
VERI, CHEK and CZOO among mid-day movers [Seeking Alpha]
Low
Report
VERI, CHEK and CZOO among mid-day movers [Seeking Alpha]
3/26
08:13 am
nuvb
Nuvation Bio Inc. (NYSE: NUVB) was upgraded by analysts at BTIG Research from a "neutral" rating to a "buy" rating. They now have a $5.00 price target on the stock.
High
Report
Nuvation Bio Inc. (NYSE: NUVB) was upgraded by analysts at BTIG Research from a "neutral" rating to a "buy" rating. They now have a $5.00 price target on the stock.
3/25
09:05 am
nuvb
Nuvation Bio falls after AnHeart Therapeutics acquisition news [Seeking Alpha]
High
Report
Nuvation Bio falls after AnHeart Therapeutics acquisition news [Seeking Alpha]
3/25
07:05 am
nuvb
Nuvation Bio to Acquire AnHeart Therapeutics in All-Stock Transaction [Yahoo! Finance]
Neutral
Report
Nuvation Bio to Acquire AnHeart Therapeutics in All-Stock Transaction [Yahoo! Finance]
3/25
07:00 am
nuvb
Nuvation Bio to Acquire AnHeart Therapeutics in All-Stock Transaction
Low
Report
Nuvation Bio to Acquire AnHeart Therapeutics in All-Stock Transaction